Vaccines and immunotherapies - Volume 27, Issue

The use of vaccines and immunotherapies in medicine dates back to the end of the 18th century and the work of Edward Jenner, the father of immunology. Jenner, building on the observations of John Fewster in 1768, showed that inoculation with the…

Pharmacovigilance for vaccines and immunotherapies - Volume 27, Issue

Although the content of EU Periodic Benefit- Risk Evaluation Reports (PBRERs) for vaccines is governed by the same regulatory framework as applies to other medicinal products, the complex nature of vaccines presents vaccine-specific challenges that…

An introduction to vaccines and immunotherapies - Volume 27, Issue

Vaccines and immunotherapies are among the largest categories for pharmaceutical products, meaning that many medical writers will work in this field. For people new to this area, we describe the basics of how vaccines and immunotherapies work.

Addressing vaccine hesitancy in writing - Volume 27, Issue

Since the infamous article by Wakefield et al. was published in 1998, diseases once nearly eradicated are re-emerging. As a result, research has focused on communication strategies that can successfully combat vaccine hesitancy. Current research…

HIV vaccine clinical trials: An overview - Volume 27, Issue

More than 30 years after the discovery of the human immunodeficiency virus as the agent that causes AIDS, an effective vaccine against this deadly disease has yet to be developed. The pathway to the development of a vaccine has been riddled with…

Vaccines and Immunotherapies - Volume 27, Issue

News from the EMA - Volume 32, Issue

Anuradha Alahari (section editor)   EMA recommends revocation of authorisation for sickle cell disease medicine Adakveo OPEN framework extended to a wider range of medicines Global regulators agree on way forward to adapt COVID-19 vaccines to…

Regulatory Public Disclosure - Volume 30, Issue

Editorial In the first half of 2021, keeping up with the regional regulators’ activities on COVID-19 medicines became a competitive sport. FDA’s Emergency Use Authorizations (EUAs), EMA’s Conditional Marketing Authorisations, and Health Canada’s…

Medical Communications and Writing for Patients - Volume 33, Issue

Section Editor: Lisa Chamberlain James Encouraging vaccination through clever and abstruse incentives Author: Yannick Borkens The COVID-19 pandemic kept the world on tenterhooks for several years beginning in 2019. Well over 7 million people had…

Digital Communication - Volume 30, Issue

The past two years have confronted humanity with a variety of unprecedented challenges due to the far-reaching COVID-19 pandemic. In response to this tragedy have come monumental new advances in science and technology – namely the vaccines developed…